Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04739059 |
|---|---|
| Brief Title: | Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema Attacks |
| First Submitted : | February 1, 2021 |
| First Submitted that Met QC Criteria : | February 1, 2021 |
| First Posted : | February 4, 2021 |
| Last Update Submitted that Met QC Criteria : | May 7, 2024 |
| Last Update Posted : | May 8, 2024 |